Multi-site, Randomized, Opened and Controlled Comparison Study on the Effectiveness and Safety of Solifenacin Succinate Tablets and Solifenacin Succinate Tablets + Estrogen for Overactive Bladder in the Post-menopausal Women
This study is a multi-site, randomized, opened and parallel-controlled clinical study.
The patients up to the inclusion criteria are randomly treated with Solifenacin Succinate Tablets (5mg/d) or Solifenacin Succinate Tablets (5mg/d) + local estrogen for 12 weeks. Before the dosing and at Week 4, 8 and 12 of the dosing, various examinations are made, and various indices are evaluated.
100 Clinical Results associated with Beijing CAT Science Co., Ltd.
0 Patents (Medical) associated with Beijing CAT Science Co., Ltd.
100 Deals associated with Beijing CAT Science Co., Ltd.
100 Translational Medicine associated with Beijing CAT Science Co., Ltd.